Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Technology in Cancer Research & Treatment
|
September 7, 2010
CyberKnife radiosurgery for prostate cancer
Alan J Katz
Frontiers in Oncology
|
June 2, 2012
Stereotactic Body Radiation Therapy for Low- and Low-Intermediate-Risk Prostate Cancer: Is there a Dose Effect?
Alan J Katz, Michael Santoro, Richard Ashley, et al.
Radiation Oncology (London, England)
|
May 15, 2013
Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years
Alan J Katz, Michael Santoro, Fred Diblasio, et al.
Technology in Cancer Research & Treatment
|
November 13, 2010
Stereotactic body radiotherapy as boost for organ-confined prostate cancer
Alan J Katz, Michael Santoro, Richard Ashley, et al.
BMC Urology
|
February 4, 2010
Stereotactic body radiotherapy for organ-confined prostate cancer
Alan J Katz, Michael Santoro, Richard Ashley, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Discrete protein dynamics enable long-range communication
Alan J Katz, Levent Sari, Leigh J Manley, et al.
Journal of Neurointerventional Surgery
|
January 27, 2012
Cyberknife radiosurgery in treating trigeminal neuralgia
Bryan M Lazzara, Orlando Ortiz, Ritu Bordia, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 25, 2021
Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients
Ritchell van Dams, Naomi Y Jiang, Donald B Fuller, et al.
Advances in Radiation Oncology
|
September 29, 2021
Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series
Jesus E Juarez, Tahmineh Romero, Constantine A Mantz, et al.
JAMA Network Open
|
February 9, 2019
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer
Amar U Kishan, Audrey Dang, Alan J Katz, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Technology in Cancer Research & Treatment
|
September 7, 2010
CyberKnife radiosurgery for prostate cancer
Alan J Katz
Frontiers in Oncology
|
June 2, 2012
Stereotactic Body Radiation Therapy for Low- and Low-Intermediate-Risk Prostate Cancer: Is there a Dose Effect?
Alan J Katz, Michael Santoro, Richard Ashley, et al.
Radiation Oncology (London, England)
|
May 15, 2013
Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years
Alan J Katz, Michael Santoro, Fred Diblasio, et al.
Technology in Cancer Research & Treatment
|
November 13, 2010
Stereotactic body radiotherapy as boost for organ-confined prostate cancer
Alan J Katz, Michael Santoro, Richard Ashley, et al.
BMC Urology
|
February 4, 2010
Stereotactic body radiotherapy for organ-confined prostate cancer
Alan J Katz, Michael Santoro, Richard Ashley, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Discrete protein dynamics enable long-range communication
Alan J Katz, Levent Sari, Leigh J Manley, et al.
Journal of Neurointerventional Surgery
|
January 27, 2012
Cyberknife radiosurgery in treating trigeminal neuralgia
Bryan M Lazzara, Orlando Ortiz, Ritu Bordia, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 25, 2021
Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients
Ritchell van Dams, Naomi Y Jiang, Donald B Fuller, et al.
Advances in Radiation Oncology
|
September 29, 2021
Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series
Jesus E Juarez, Tahmineh Romero, Constantine A Mantz, et al.
JAMA Network Open
|
February 9, 2019
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer
Amar U Kishan, Audrey Dang, Alan J Katz, et al.
Page
of 2